INova Pharmaceuticals, part of the Valeant Pharmaceuticals International group of companies, is reviewing its media agency options, AdNews understands.
INova, which has a local media spend, including search and social, of about $8 million, sits with IPG's Initiative - which is headed up by Sydney-based CEO Lee Leggett.
As agencies increasing look to diversify their verticals due to the frequent conflicts of interest that arise with new business being up for grabs, the pharma sector seems a strong bet, with at least three local agencies said to have their hat in the ring.
The business pegs itself as a diversified pharmaceutical company that markets a range of over the counter and prescription medicines to Australia, Asia Pacific, South Africa and other international markets.
The review is the second revealed this week with Huckleberry client Simplot, which owns brands such as Birds Eye and John West, calling a media review after the recent Dentsu shake-up.
According to Nielsen Simplot's media spend is about $11.9million.
A spokesman from Simplot told AdNews: “Simplot Australia has confirmed that it is currently reviewing its media agency options, following the recent decision by Dentsu to close it Huckleberry office.”
Inova, which has a local media spend, including search and social, of about $8 million, is reviewing its media agency options, AdNews understands.
Have something to say on this? Share your views in the comments section below. Or if you have a news story or tip-off, drop us a line at adnews@yaffa.com.au
Sign up to the AdNews newsletter, like us on Facebook or follow us on Twitter for breaking stories and campaigns throughout the day.